Table 1.
Data from questionnaires and clinician evaluations.
Assessment | |||
---|---|---|---|
Interview/Questionnaires | Pre-treatment | Post-treatment | 6-month follow-up |
ADIS-IV-L: | Clinical social phobia, generalized | Subclinical social phobia | No diagnosis |
CSR: 5 | CSR: 2 | ||
clinician rated: | |||
LSAS – Fear | 36 | 15 | 18 |
LSAS – Avoidance | 40 | 0 | 2 |
John rated: | |||
LSAS – Fear | 43 | 21 | 17 |
LSAS – Avoidance | 34 | 0 | 5 |
PRCS | 27 | 14 | 12 |
ACQ-tot | 63 | 92 | 94 |
SPAI-Social | 131 | 53 | 69 |
SPAI-Agoraphobia | 25 | 9 | 10 |
SPAI-total | 106 | 44 | 59 |
FQ | 34 | 11 | 12 |
SSPS-positive | 4 | 13 | 13 |
SSPS-negative | 6 | 5 | 9 |
BDI | 12 | 7 | not assessed |
STAI-Trait | 56 | 41 | 42 |
Note. The table shows John’s diagnostic information and questionnaire data at pre-treatment, post-treatment, and the 6-month follow-up assessment. CSR: Clinical Severity Rating (0–8, with 4 being the threshold for a clinical diagnosis); LSAS: Liebowitz Social Anxiety Sale, Fear: Fear scale total score (0–72); Avoidance: Avoidance scale total score (0–72); PRCS: Personal Report of Confidence as a Speaker (0–30); ACQ-tot: Anxiety Control Questionnaire, sum score (0–150); SPAI-social: Social Phobia and Anxiety Inventory, social anxiety subscale (0–192), confidence interval (CI) for 68%: 113.3 +/− 23.3, CI for 95%: 113.3 +/− 45.7; SPAI-Agoraphobia: Social Phobia and Anxiety Inventory, agoraphobia subscale (0–78), CI for 68%: 17.7 +/− 11.0, CI for 95%: 17.7 +/− 21.6; SPAI-total: Social Phobia and Anxiety Inventory, total score (0–192), CI for 68%: 95.6 +/− 22.4, CI for 95%: 95.6 +/− 43.9; FQ: Fear Questionnaire (0–128); SSPS-positive: Self-Statements during Public Speaking, positive statements (0–25); SSPS-negative: Self-Statements during Public Speaking, negative statements (0–25); BDI: Beck Depression Inventory (0–63); STAI-Trait: Trait subscale of the State-Trait Anxiety Inventory (20–80).